HC Wainwright & Co.:维持Soleno Therapeutics评级

证券之星
31 Mar

HC Wainwright&Co.:维持Soleno Therapeutics(SLNO.US)评级,由买入调整至买入评级,目标价由70.00美元调整至100.00美元。Soleno Therapeutics(SLNO.US)公司简介:Soleno Therapeutics Inc致力于治疗罕见病的新型疗法的开发和商业化。其候选产品包括二氮嗪胆碱控制释放片,它是用于治疗Prader-Willi...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10